Clinical Trials Directory

Trials / Completed

CompletedNCT01710722

The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to compare three treatments to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol.

Detailed description

Three treatments are compared to see which causes the most weight loss, fat loss, loss of stomach fat and improvement in blood tests like cholesterol. 1\) Leptin A-200 injections daily with 2 inactive pills taken three times a day, 2) Caffeine with ephedrine pills taken 3 times a day with an inactive injection daily and 3) Both Leptin A-200 injections daily and caffeine with ephedrine pills taken three times a day.

Conditions

Interventions

TypeNameDescription
DRUGcaffeine and ephedrineCaffeine 200 mg tablets and ephedrine HCl 25 mg tablets three times a day with placebo leptin A-200 subcutaneously once daily.
DRUGLeptin ALeptin A-200 20 mg subcutaneously once daily and placebo tablets of caffeine and ephedrine three times a day.
DRUGcaffeine, ephedrine, and leptin ACaffeine 200 mg tablets and ephedrine HCl tablets 25 mg three times a day with leptin A-200 20 mg subcutaneously once daily.

Timeline

Start date
2001-02-01
Primary completion
2002-02-01
Completion
2002-02-01
First posted
2012-10-19
Last updated
2015-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01710722. Inclusion in this directory is not an endorsement.